Cutaneous and Visceral Leishmaniasis Caused by the Same Zymodeme of Leishmania donovani in Kerala, India

被引:6
|
作者
Saini, Prasanta [1 ,5 ,6 ]
Fathima, Pananchikkaparambil Abdu [1 ]
Aiswarya, Rema Suresh [1 ]
Ajithlal, Puthenpurackal Madhavan [1 ]
Rajesh, Koothupalakkal Ravi [2 ]
Simi, Surendran Maheswari [3 ]
Kumar, Narendran Pradeep [1 ]
Kumar, Ashwani [4 ]
机构
[1] Field Stn, Vector Control Res Ctr, Indian Council Med Res, Kottayam, India
[2] Govt Med Coll, Dept Infect Dis, Trichur, India
[3] Sree Gokulam Med Coll Hosp, Dept Dermatol, Thiruvananthapuram, India
[4] Vector Control Res Ctr, Indian Council Med Res, Pondicherry, India
[5] Indian Council Med Res, Vector Control Res Ctr, Field Stn, Kottayam, Kerala, India
[6] Field Stn, Indian Council Med Res, Vector Control Res Ctr, Kottayam 686003, Kerala, India
来源
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2024年 / 110卷 / 01期
关键词
WESTERN-GHATS; FOREST; DNA; PCR;
D O I
10.4269/ajtmh.22-0586
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The tribal population in and around the Western Ghats region of India is affected by both cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) with typical clinical symptoms. In this study, we recorded and analyzed seven CL and three VL cases from this emerging belt. All the cases were found as autochthonous transmission. Multiple genetic markers (minicircle kinetoplast DNA polymerase chain reaction and restriction fragment length polymorphism of 39untranslated region heat shock protein (HSP) 70, a larger segment of HSP 70, and 6-phosphogluconate dehydrogenase [PGDH] gene sequences) were used to identify and characterize the parasite. It was found that both clinical manifestations are caused by zymodeme MON-37 of Leishmania donovani. We have investigated the detailed entomological and epidemiological aspects of disease transmission. An abundant population of the proven vector Phlebotomus argentipes was observed in the study villages.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [41] Serological studies on rK39 negative Visceral Leishmaniasis in an endemic focus of Leishmania donovani induced Cutaneous Leishmaniasis
    Deepachandi, Bhagya
    Weerasinghe, Sudath
    Soysa, Preethi
    Chatterjee, Mitali
    Siriwardana, Yamuna
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 105 (03)
  • [42] In vitro Susceptibility of Leishmania donovani to Miltefosine in Indian Visceral Leishmaniasis
    Prajapati, Vijay Kumar
    Sharma, Smriti
    Rai, Madhukar
    Ostyn, Bart
    Salotra, Poonam
    Vanaerschot, Manu
    Dujardin, Jean-Claude
    Sundar, Shyam
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (04): : 750 - 754
  • [43] PURE PROTEIN FROM LEISHMANIA-DONOVANI PROTECTS MICE AGAINST BOTH CUTANEOUS AND VISCERAL LEISHMANIASIS
    RACHAMIM, N
    JAFFE, CL
    JOURNAL OF IMMUNOLOGY, 1993, 150 (06): : 2322 - 2331
  • [44] The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani
    Varikuti, Sanjay
    Volpedo, Greta
    Saljoughian, Noushin
    Hamza, Omar M.
    Halsey, Gregory
    Ryan, Nathan M.
    Sedmak, Bren E.
    Seidler, Gabriella R.
    Papenfuss, Tracey L.
    Oghumu, Steve
    Satoskar, Abhay R.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (04): : 599 - 608
  • [45] The increased inflammatory monocytes are the hallmark of human visceral leishmaniasis caused by Leishmania donovani: the activation of signature chemokines
    Dey, S.
    Mukherjee, D.
    Patra, P.
    Pal, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1200 - 1200
  • [46] A new Leishmania tropica zymodeme -: causative agent of canine visceral leishmaniasis in northern Morocco
    Lemrani, M
    Nejjar, R
    Pratlong, F
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2002, 96 (06): : 637 - 638
  • [47] In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani
    Manamperi, N. H.
    Oghumu, S.
    Pathirana, N.
    de Silva, M. V. C.
    Abeyewickreme, W.
    Satoskar, A. R.
    Karunaweera, N. D.
    PARASITE IMMUNOLOGY, 2017, 39 (03)
  • [48] First identification of the causative agent of visceral leishmaniasis in Djibouti:: Leishmania donovani
    Pratlong, F
    Debord, T
    Garnotel, E
    Garrabé, E
    Marty, P
    Raphenon, G
    Dedet, JP
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2005, 99 (01): : 21 - 25
  • [49] Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani
    Duthie, Malcolm S.
    Goto, Yasuyuki
    Ghosh, Prakash
    Mondal, Dinesh
    PATHOGENS AND DISEASE, 2019, 77 (06):
  • [50] Leishmania donovani Dipeptidylcarboxypeptidase Inhibitor as a Potential Oral Treatment for Visceral Leishmaniasis
    Ramalingam, Karthik
    Gangwar, Sonali
    Balodi, Deep Chandra
    Anand, Apeksha
    Yadav, Shailendra
    Biswas, Subhasish
    Sasikala, Anil Kumar Karunakaran
    Gupta, Kailash Chand
    Batra, Sanjay
    Goyal, Neena
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (08)